Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIIB, Long-Term Follow-Up of CAB LA for Participants in HPTN 083 and HPTN 084 CAB PrEP Studies at Risk of HIV Acquisition

NCT06134362 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT06134362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06134362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIIB, Long-Term Follow-Up of CAB LA for Participants in HPTN 083 and HPTN 084 CAB PrEP Studies at Risk of HIV Acquisition
Lead sponsor
ViiV Healthcare
Phase
Phase 3
Overall status
Active, not recruiting
Start date
May 14, 2024
Completion date
March 14, 2029
Enrollment
2,996 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections